Table 1 Demographic and baseline disease characteristics of RA patients in two groups

Age (years)

48.50 ± 12.22

53.56 ± 10.84

0.107

Female, n(%)

22(91.7)

30(93.8)

0.770

Disease duration (months)

101.08 ± 76.14

88.38 ± 77.43

0.543

DAS28*

4.59 ± 0.96

4.97 ± 0.99

0.151

ESR(mm/h)

46.5 ± 9.23

34.1 ± 5.76

0.021

C reactive protein (mg/l)

25.72 ± 32.94

34.58 ± 34.57

0.338

SJC28

3.61 ± 2.93

3.56 ± 3.09

0.256

TJC28

3.96 ± 3.10

5.25 ± 3.31

0.144

VAS

66.63 ± 12.02

58.63 ± 12.54

0.020

HAQ

1.73 ± 0.90

2.11 ± 0.96

0.138

RF (IU/ML)

144.13 ± 151.95

324.12 ± 430.34

0.056

ACPA(IU/ML)

73.94 ± 165.48

300.70 ± 361.61

0.006

RF positive, n(%)

22(91.67)

31(96.87)

0.392

ACPA positive, n(%)

12(50.00)

25(78.12)

0.028

Drug combination

Glucocorticoid, n(%)

15(62.50)

13(20.62)

0.178

Methotrexate, n(%)

24(100)

32(100)

-

Hydroxycloroqiune, n(%)

11(45.82)

1(3.12)

0.661